Science topic

Nano Biomedicine - Science topic

Explore the latest questions and answers in Nano Biomedicine , and find Nano Biomedicine experts.
Questions related to Nano Biomedicine
  • asked a question related to Nano Biomedicine
Question
5 answers
1-The conditions of the relationship between the pigment (Pyocyanin) with Gold (Au Nanoparticles)?
2-Dose the pigment (Pyocyanin) work as Reducing agent or not?
3-Dose the pigment (Pyocyanin) endures high temperatures or not?
Relevant answer
Answer
1.Pyocyanin can be adsorbed on the surface of gold nanoparticles. It does not oxidize or reduce gold. Gold is oxidized with potassium cyanide or aqua regia.
2. When interacting with gold ions, Pyocyanin (quinone) acts as an oxidizing agent.
3. Pyocyanin melting point 133 0С.
  • asked a question related to Nano Biomedicine
  • asked a question related to Nano Biomedicine
Question
1 answer
Hi everyone!
I'm trying to produce a nanocapsule using TCM, Span 80 and Tween 80 (1:2:2 ratio) and PCL (100 mg). However, when I transfer the organic phase to the aqueous phase (interfacial deposition of preformed polymer), the PCL precipitates (no matter the parameters, i.e., temperature, rotation, etc.).
(This apply to the blank nc and the compound nc).
Does anyone have any insights?
Thanks in advance!
Relevant answer
Answer
Hi Milena,
Based on my experience I used the centrifuge to precipitate the polymer and after that, I used the freeze dryer to remove the water.
  • asked a question related to Nano Biomedicine
Question
8 answers
I want make silica coated magnets but I have several problem in procedure. I cant make high quality silica coated magnets.
Results show a poor yield so i think many of magnets don't be coated.
How can i increase silica coated magnets or how can i increase coating with silica?
How can i separate silica coated magnet and non coated magnets ?
What is the best protocols to produce silica coated magnets?
Relevant answer
Answer
Dear Ehsan Razeghian, the choice of the solvent has a detrimental role for success. Methanol is usually the best option. Please have a look at the following documents. My Regards
  • asked a question related to Nano Biomedicine
Question
2 answers
I have synthesized mesoporous silica nanoparticles and removed the CTAB via ethanol. Can this ethanol be used again for the removal of CTAB from another batch of mesoporous silica nanoparticles or using fresh ethanol is preferred each time?
I'd be grateful for your guidance
Relevant answer
Answer
Riaz A. Khan recovering the ethanol and reuse it for the next batch of mesoporous silica nanoparticles.
  • asked a question related to Nano Biomedicine
Question
1 answer
Starting from the genetic sequence of an mRNA, is it possible to allow the self-assembly of graphene nanoparticles (GQD - Graphene Quantum Dots), in such a way as to obtain certain circuits, with the formation of specific electronic components at the nanoscale? With what correlation between the triplets and the electronic scheme?
Thank you.
Relevant answer
Answer
Kira, Unfortunately, this question is not in the area of my expertise. I would be conjecturing too much to qualify the answer as scientifically validated. I apologize.
  • asked a question related to Nano Biomedicine
Question
6 answers
Nanoparticles have been extensively studied in the field of drug loading and toxicology. Although the size of nanoparticles is an important nature that affects their behavior in vivo , I have not found appropriate method to measure their size in physiological fluids ? Which method is better for analyzing physiological fluids?( e.g. DLS, TEM/SEM, NTA , AFM ...)
I mainly want to konw is whether the size of nanoparticls changes or not as they enter the body.
Relevant answer
Answer
I wish that there was an easy answer. TEM is probably the best absolute measurement approach, but it requires being careful about statistics, and being aware of artifacts associated with drying the sample. DLS is in principle better for hydrated systems but at high ionic strength aggregation is likely. The tradeoffs are presented well here:
  • asked a question related to Nano Biomedicine
Question
5 answers
Hi.
We have some carbon nanoparticles and want to check antibacterial activity against drug-resistant bacteria. Before working on drug-tolerant bacteria, Are there any protocols or parameters for checking nanoparticles whether have the antibacterial capability on drug-resistant bacteria?.
Relevant answer
Answer
Follow
  • asked a question related to Nano Biomedicine
Question
3 answers
Hi.
I have prepared hetero-atom-doped carbon dots (Nitrogen with sulfur, boron, phosphorous) for the eradication of biofilm of drug-resistant bacteria. But, I did not see any bacterial death at low concentrations when I am using doped carbon dots. Should I change any parameters or something else?
Relevant answer
Answer
Dear Saravanan Arumugam thanks for sharing this very interesting technical question with the RG community. Personally I'm not an exert in this field of reserach (we are inorganic / organometallic chemists) and I was not even aware of the fact that hetero-atom-doped carbon dots have antibacterial properties. However, there are various reports in the literature in which this effect has been demonstrated. For example, please have a look at the following potentially useful articles which migth help you in your analysis:
Applications of N-Doped Carbon Dots as Antimicrobial Agents, Antibiotic Carriers, and Selective Fluorescent Probes for Nitro Explosives
and
Antibacterial Activity of Nitrogen-Doped Carbon Dots Enhanced by
Atomic Dispersion of Copper
The first article is freely available as public full text, while the second has been published Open Access (please see attached pdf file). Apparently it might be worth a try using the hetero-atom-doped carbon dots in combination with copper or silver nanoparticles for enhanced antibacterial activity.
Good luck with your work!
  • asked a question related to Nano Biomedicine
Question
3 answers
I have synthesized carbon dots that exhibit fluorescent properties, that are further coated with PEG through EDC. I want to separate them through gel electrophoresis based on the number of PEG attachment. Is the gel electrophoresis for Carbondots any different than gel electrophoresis for nucleic acids ?
Relevant answer
Answer
Santosh K. Tiwari Thank you for responding I'll look into these
  • asked a question related to Nano Biomedicine
Question
14 answers
Hello, can anyone please named few potential drug delivery technologies that you think are novel and unique. Our comapny is looking to buy few drug delivery technologies that can serve us to compete for now and few next years. Suggestions are highly appreciated. Thanks in advance.
Regards
Relevant answer
Answer
Current trend is Nanotechnology based drug delivery systems like nanogels, Hydrogels for wound healing, surgical sprays, Monoclonal antibodies are in high demand in this covid state and many companies are even having patents.
  • asked a question related to Nano Biomedicine
Question
45 answers
I know there are many reasons why bacteria are multi-drug resistant, but I want to know your opinion on which one is the primary cause of this problem.
I'm conducting research on this problem right now so your help is appreciated.
Relevant answer
Answer
Dear Hevar, several multiple factors are responsible for antimicrobial resistance. These include suboptimal prescribing and inadequate adherence to completion of prescribed antibiotic courses, misuse and Over use of antibiotics in humans and animals and Poor infection prevention and control in health care settings.
  • asked a question related to Nano Biomedicine
Question
4 answers
I have biofunctionalized o-MWCNT with 2 recombinant proteins; the proteins had 10 histidine tags to attach to the o-MWCNT. After dispersing in media (without serum) to incubate with cells less than 24h o-MWCNT intensively aggregate (37C incubator). I have changed the media (less glucose and salt) and tried to improve biofunctionalization (for better coating), although the measures were inefficient.
Relevant answer
Answer
Discussion of the problem in this place raises questions that need to be constantly asked to each other. If you want me to help you, write in detail the composition of your mixture and your actions, your problems in a personal letter.
  • asked a question related to Nano Biomedicine
Question
2 answers
Does the downsizing affect the pore size or pore number in the nanoMOFs?
I know that the nanoMOFs retain their crystalline structures as their bulk parents, and for example, if we reduce the size of a bulk MOF to smaller than 10 nm, it's surface area will increase, but for meso MOFs with pore size of 2 nm or more (PCN-224, for example), How will be the porosity? Could be possible to produce such nanoscale meso MOFs?
Relevant answer
Answer
Dear Naime,
I suggest that you read the following paper:
Please let me know if you are unable to download it.
Kind regards,
Bahram
  • asked a question related to Nano Biomedicine
Question
8 answers
I have collected 6h to 96h drug release data for unilamellar liposomal vesicle by using spectrophotometer. According to data, we have encapsulated chemotherapeutic agent in 80% efficiency. But when we look at the release profile, liposomes do release the drug at minimum level even at the 96h. Is it possible ? What are the reasons behind that ? Is minimum releasing okay ? What are the consequences of this thightly encapsulation ?
Relevant answer
Answer
Hello,
The release profile of the encapsulated drug in strongly influenced by the characteristics of the release medium. For instance, low solubility of the target chemotherapeutic in the employed release medium might be the reason for your observations. Several other factors such as stability of the carrier and interactions between drug and carrier could also affect the release profile. Overall, all of these factors must be carefully considered in order to draw an accurate interpretation.
Furthermore, drug encapsulation efficiency and release profile are two independent factors and in some instances, one might not even be affected by the other, therefore, it is best not to use one of these factors for interpretation of the other one.
  • asked a question related to Nano Biomedicine
Question
1 answer
I could not synthesize Selenium nanoparticles by PEG 200 at up-scale ( more than 100 ml) as it got aggregated while at small amounts it works fine , I work with 850 PPM using selenium powder in PEG 200 heated to around 200 degree. What is the problem?
Relevant answer
Answer
Amr Mahmoud Scale-up of nanoparticles needs optimization as most nanoparticle synthesis is easy at small amounts. In this case, I would suggest using a higher concentration or molecular weight of PEG. The following article might be of some help to you. " Challenges posed by the scale-up of nanomedicines " DOI: 10.2217/nnm.12.3
  • asked a question related to Nano Biomedicine
Question
8 answers
I'm trying to make Nanostructured lipid carriers (NLC) using ultrasonicator method for cancer meds that are hydrophobic and insoluble in water. I'm heating solid and liquid lipid phase and then adding meds to it and then slowly adding aqueous phase to it which consists of water and poly 80.
Then I sonicate this mixture in ultrasound sonicator to generate nanoparticles.
My question is, does reducing size and encapsulation in lipid increase absorption and bioavailability against cancer cells? I'm not using any solvents. Do I need to? Shouldn't the insoluble drug essentially become soluble once it's particle size is reduced by ultrasonicator ?
Please help. Thanks a lot.
Relevant answer
Answer
Dear all, solubility depends on the chemical structure and types of existing intermolecular forces. Excessive sonication may degrade any of the compounds present in the recipe. There are many techniques to solubilize poorly soluble drugs. Please check the following links. My Regards
  • asked a question related to Nano Biomedicine
Question
1 answer
Hi everybody: i am looking for recent datas about the amount of registered biocides containing silver nanoparticles. The most recent data i found is in this paper from Nowack et al. (2011) which explains that about the 53% of biocides registered at EPA contains nanoAg and the 7% of it contains AgNPs. I looked for more recent datas/numbers about biocides cointaining nanoAg/AgNPs, but from main sites like EPA's, REACH's and ECHA's or from the huge amount of papers i read nothing came out. I was wondering if someone has something (papers, reviews, sites etc..) to share with me to help my research. Everything is accepted but it must be referred to biocides containing nanoAg/AgNPs.
Thanks a lot to everyone who will share his/her time with me
Mattia
Relevant answer
Answer
Silver nano-particles are toxic to varieties of organisms. Silver-based biocidal material is used for commercial & healthcare textiles.They have exhibited 99% efficacy against the spread of bacteria. They also showed a broad spectrum.fungicidal activity. As far as the mechanism of action is considered Silver nano-particles release silver ions, which act as the biocidal species .
  • asked a question related to Nano Biomedicine
Question
6 answers
Hi, I'm trying a procedure to synthesis nano ZIF-90 in water for specific application, but there is some problem. pxrd pattern for as-synthesized MOF is not completely compatible with charactristic XRD pattern of ZIF-90, in terms of tetha. on the other side, as article indicated, i choose 1 to 40 ratio of zinc acetate to 2-imidazole carboxaldehyde to obtain particles with the scale of 100 nm, but led to really low yield, there is not another way to reach nanosize ZIF-90? I appreciate if anyone has the same experience and could help me.
Relevant answer
Answer
Naeimeh Hassanzadeh Goji Anytime. I did not also find the hydrate structure. Maybe it hasn't been reported, yet. You can give it a trial. Good Luck!
  • asked a question related to Nano Biomedicine
Question
4 answers
Ethylenediamine is attached to the surface of iron oxide nanoparticles via electrostatic interactions, what the effects of inhaling a very small quantity of these nanoparticles may be? Pure ethylenediamine is toxic, but it would exert its toxicity for as long as the nanoparticles stay in the lungs or weak bond would be broken,leaving only the naked iron oxide nanoparticles?
Relevant answer
Answer
I don't think, it would be much toxic then. If you are working in applications where biocompatibility really matters, then you may do some standard toxicity tests for better acceptability of your publication. But, if you are working in physical or engineering aspects, you may simply ignore it...
  • asked a question related to Nano Biomedicine
Question
22 answers
Resistant microorganisms (including bacteria, fungi, viruses and parasites) are able to withstand attack by antimicrobial drugs, such as antibacterial drugs (e.g. antibiotics), antifungals, antivirals, and antimalarials, so that standard treatments become ineffective and infections persist, increasing the risk.
It is an increasingly serious threat to global public health that requires action across all government sectors and society.Antimicrobial resistance is present in all parts of the world. New resistance mechanisms emerge and spread globally.
Can someone Provide/share some innovative ideas to combat AMR
  • asked a question related to Nano Biomedicine
Question
2 answers
We want to determine the antioxidant effects of our prepared formulation of nanoparticles by DPPH method. Our formulation is having some col and different excipients/vehicles. Please also tell how to compare the results with the bulk form of our compound.
Relevant answer
Answer
It could be useful
https://www.researchgate.net/publication/276835325_Alginate-pomegranate_peels'_polyphenols_beads_Effects_of_formulation_parameters_on_loading_efficiency
  • asked a question related to Nano Biomedicine
Question
7 answers
Hi dear researchers
Is it possible that observed increase of Km for one substrate and decrease for another one (for enzymes with two substrates such as HRP) after immobilization?
Relevant answer
Answer
Dear Soudabeh,
I had immobilized my enzyme and observed a change in the Km value. However, mine was a single substrate specific enzyme. I second the opinion of Tapan Kumar; the pore sizes, the immobilization technique used, etc., could play a role in the availability of the reactive site to your substrate.
  • asked a question related to Nano Biomedicine
Question
9 answers
What are the most promising fields of nanomedicine? In essence, how can applications of nanotechnology in the medical field revolutionize the current health standards?
Relevant answer
Answer
One of the most important applications is the treatment of cancer
  • asked a question related to Nano Biomedicine
Question
5 answers
I need some articles presenting nanoparticles use for gene therapy in details. In addition, their synthesis and mechanism of action
Thanks in advance
Relevant answer
Answer
https://www.nature.com › gene therapy › news and commentary
  • asked a question related to Nano Biomedicine
Question
6 answers
What do you think are the major barriers or causes which stop nano particles from entering into mainstream treatment of lethal diseases in spite of success at lab scale?
Relevant answer
Answer
It is so challenging to get stable nanoparticles with high drug loading. Moreover, active targeting has many limitations that impede its applicability.
  • asked a question related to Nano Biomedicine
Question
6 answers
Mathematical and computational methods are expected to play a major role in nanoscience and nanoengineering. Mathematics and computation can provide effective theory and simulations for analysis and interpretation of experimental results, model-based prediction of nanoscale phenomena, and design and control of nanoscale systems.
Relevant answer
Answer
Reminds me of: 'In theory, theory and practice agree. In practice they do not'
I would always believe one well-conducted experiment over one paper with more Greek letters than an Athens post-office.....
  • asked a question related to Nano Biomedicine
Question
4 answers
Whether its Silver nano particles or Au nanoparticles?
Relevant answer
Answer
Gold and Silver nanoparticles is seen in Alternanthera sessilis
  • asked a question related to Nano Biomedicine
Question
9 answers
we may faced problem in removing plant extract from silver nano particles. If we check pharmacological activity as such we may not able to discuss the exact mechanism by which these particles show the activity.
Relevant answer
Answer
Subha Kandiyar we are washing in order to remove the un-reacted moieties and the loosely bound capping agent. So that the surface of our nano are free for activities
  • asked a question related to Nano Biomedicine
Question
97 answers
How to make fun of what you have if you are uneducated and have non-academic skills to become a successful researcher?
Relevant answer
Answer
1) You must allocate at least 3 hours per day to research
2) Read the latest research in your specialty
3) Communicate with researchers from other countries
4) Try to find new search points
  • asked a question related to Nano Biomedicine
Question
4 answers
i have to make nano size phtocatalyst that is Fe doped Tio2...kindly tell me how to prpare x mol % or wt % of fe-tio2...means how many grams or moles of fe and tio2 are required to make x mol % or wt %..here x=0.01, 0.05 mol % or wt %?
Relevant answer
Answer
Hello, Nusrat Afzul,
Have you solved your mol% problem, please?
If not, I might help you here. I am looking forward to hearing from you.
  • asked a question related to Nano Biomedicine
Question
9 answers
Hi,
There are many studies about functionalizing different ZnS nanostructures. but i couldn't find anything about ZnS nanotube. Is it possible, at all?
would you please share me your experiences? is there any theoretical or experimental studies about it?
Best
Relevant answer
Answer
Please see some links about ZnS nanotubes in the attached file.
  • asked a question related to Nano Biomedicine
Question
2 answers
DNA is a polymer whose repeating unit contains a phosphate group (PO4), a ribose ring, and a DNA base, which can be either Adenine (A), Thymine (T), Guanine (G), or Cytosine (C); the phosphate group and ribose ring don't vary. The Carbon atoms in the base are numbered 1 through however many that base has, and those in the ribose are numbered 1' through 5'. The 5' carbon of the ribose ring is covalently bonded to one of the oxygens of the phosphate group, while the 3' carbon of the ribose ring is bonded to (a different) one of the oxygens of the next phosphate group; hence biologists commonly refer to the "5' end" and "3' end" of a DNA strand. The phosphate at the 5' end of a strand "normally" just won't have anything bound to it (although sometimes the 5' end of a DNA or RNA strand will get modified for the purpose of some cellular process); while 3' carbon of the base at the 3' end of a strand will have an OH group instead of the O of the next phosphate.
Relevant answer
Answer
DNA base blending is easy to display (in any event on an abnormal state) and therefore simple to program, while supplanting the 3'- OH assemble with SH influences them to cling to gold nanoparticles.
In the papers depicted in the connection, there are three sorts of items included: gold nanoparticles, non-complimentary 3'- thiol DNA oligonucleotides, and a connecting DNA duplex.
Foundation for those new to sub-atomic science: DNA is a polymer whose rehashing unit contains a phosphate gathering (PO4), a ribose ring, and a DNA base, which can be either Adenine (A), Thymine (T), Guanine (G), or Cytosine (C); the phosphate gathering and ribose ring don't change. The Carbon molecules in the base are numbered 1 through anyway numerous that base has, and those in the ribose are numbered 1' through 5'. The 5' carbon of the ribose ring is covalently attached to one of the oxygens of the phosphate gathering, while the 3' carbon of the ribose ring is clung to (an alternate) one of the oxygens of the following phosphate gathering; thus researcher usually allude to the "5' end" and "3' end" of a DNA strand. The phosphate at the 5' end of a strand "typically" just won't have anything bound to it (albeit now and then the 5' end of a DNA or RNA strand will get changed with the end goal of some phone procedure); while 3' carbon of the base at the 3' end of a strand will have an OH bunch rather than the O of the following phosphate. The 1' carbon is clung to the base. The structure of the bases implies Adenine and Thymine bases of various strands normally frame hydrogen bonds with each other (A with T, not A with An or T with T), as do Guanine and Cytosine, so if two DNA strands which have long strings of corresponding arrangement (frequently regardless of whether a couple of bases are befuddled), they will normally shape into the celebrated twofold helix shape. The supplement of a strand's succession is acquired by turning around the grouping and after that trading A with T and C with G, since this base blending is constantly antiparallel. This makes DNA effectively "programmable", since in the event that you need two things to tie, make two integral DNA successions, connect balanced and the other to the next.
This programmability of DNA strand restricting is the fundamental purpose of the paper. Initially, single strands of DNA are appended to gold nanoparticles by supplanting the OH assemble on the 3' carbon of the 3' end ribose with a SH (sulfur + hydrogen, otherwise called thiol) gathering, which ties to gold. (Sulfur has numerous comparable synthetic properties to Oxygen, being in a similar section of the intermittent table, so the substitution is sensible.) In a basic model, you would append say TTAG (DNA groupings are by and large composed from the 5' base; for this situation the ribose of the G base would have the thiol gathering) to one nanoparticle and CTAA (the integral arrangement) to alternate; this won't work for one, and perhaps two reasons. The first is that the more bases in a corresponding succession, the more grounded the bond is, and 4 bases happens to be not sufficiently solid to hold together at room temperature. (From the heuristics I utilize, despite the fact that I don't really utilize these a considerable measure so they may be off, 5-7 bases at room temperature is generally equivalent vitality bound versus unbound and in this manner will return and forward, while essentially more will remain bound and fundamentally less won't tie for any apparent time allotment. For this reason, the creators need something to remain bound at room temperature, and afterward unbind at higher temperature. The 8-base succession they utilize, so they assert, has a dissolving temperature of 42 degrees C.) The second, which they don't discuss, however I think, might be that the separation of a short arrangement is too little and would be liable to steric obstruction; the nanoparticles being not able get that nearby. On the off chance that that is not valid, at that point it's not by any stretch of the imagination clear to me why they utilize the linker duplex.
Along these lines, the writers join AGTCGTTT-3'- thiol TACCGTTG-3'- thiol strands to the gold nanoparticles, which are not reciprocal to each other (or to themselves; self-complementarity is every so often an issue in strand plan) and in this manner don't associate, yet. They at that point include a linker duplex, made out of ATGGCAAC-TATACGCGCTAG and CTAGCGCGTATA-AAACGACT strands. Note that the 12-base spaces of the linker strands are integral to each other, while the 8-base areas are every corresponding to one of the thiol oligonucleotides. Along these lines each thiol-oligonucleotide hybridizes to one of the strands in the linker duplex, which hybridize to each other, shaping an association between two nanoparticles. Since each nanoparticle has various strands of whichever compose it has, and there are a ton of duplicates of linker duplex in arrangement, totals shape
regards
  • asked a question related to Nano Biomedicine
Question
10 answers
I am trying to determine the best possible method to measure the impedance on my monolayer of MDCK (Madin Darby Canine Kidney) epithelial cells. 
Does this require a specific metallic coating (via sputter coater or another method) on/ under (as a membrane the cells would grow on) my monolayer or would the liquid media itself simple provide the conductive element required?
Relevant answer
Answer
Our company develops 3D cell barrier culture systems for in vitro study of virtually any cell barrier, and the system comes equipped with both a Fluid Perfusion Unit and a Trans-Endothelial/Epithelial Electrical Resistance (TEER) Measurement Unit! The use of a vessel-shaped 3D environment has been proven more effective than 2D systems like Transwell (
Article Santaguida S, Janigro D, Hossain M, Oby E, Rapp E, Cucullo L...
), and our advanced TEER Measurement Unit allows for frequency sweeps between 0.1-1,000 Hz, automated time point sampling, logging of data to Excel, and additional measurement of phase angle for cell capacitance calculations! For those that are committed to Transwell use, we also have a TEER Measurement Unit that is compatible with nearly all Transwell products (Endohm cell cup chamber, STX2 "chopstick" electrodes, etc) and allows the user to greatly expand their testing capabilities with Transwell equipment. Additionally, we have smaller modular systems that connect to microscope-friendly cell culture modules: i.e., a miniaturized 3D cell culture system that you can use right under your microscope! If you or anybody on this thread is interested in learning more, I encourage you to visit www.flocel.com or email me at djanigro@flocel.com, thank you!
  • asked a question related to Nano Biomedicine
Question
10 answers
Dear all,
I want to run the molecular dynamics simulation of an infinite graphene sheet solvated in water using NAMD code. I don't know how to create an infinite sheet with it's periodic images. Should I add bonds between graphene and it's periodic images or is not needed?
Would be so much thankful to help me..
All the Best,
Zeynab
Relevant answer
Here is the NAMD mailing list where Josh answered me exactly how to do that along with all details :
  • asked a question related to Nano Biomedicine
Question
4 answers
Drug release study requires taking absorbance of samples at absorption maxima (Lambda max) of drug. What should be the approach in case of poly herbal formulation (nanogel). There are atleast 5 active components in the nanogel with different absorption maxima.
In this case, at what lambda max should the absorbance be taken?
Relevant answer
Answer
you can use HPLC with program sequence of diffrent lamda maxima & can anlyze the release quantity of drug.In primary stage you have to validate your method.
  • asked a question related to Nano Biomedicine
Question
5 answers
Recently, many reports have shown the adjuvant effect of ZnO nanoparticles or nanowires.
Some are showing good immunotherapeutic effects also. I am curious if anyone can help me to find out how ZnO is assisting the immune system.
I mean is there any specific mechanism?
Relevant answer
Answer
Hello
This is an interesting topic.
Zn is useful in the body in very small amounts and ZnO helps to enrich the blood with oxygen. This makes it possible to enrich the regeneration of red blood cells. The remaining Zn is excreted through the syringe system or accumulates in the bones if it is in increased doses.
  • asked a question related to Nano Biomedicine
Question
2 answers
I dont no
Relevant answer
Answer
  • asked a question related to Nano Biomedicine
Question
4 answers
Nanotechnology is an emerging technology for fabricating nanostructures where at least one dimension is smaller than 100 nm.
The development of easy, low-cost and high-throughput techniques for the fabrication of nanostructures has been of great interest for both the possibility to increase the device packing density and for reducing the power consumption, as well as the creation of a new class of nano-electronic devices
Relevant answer
Answer
Our group has been working for developing nanogap by atomic layer lithography in which the gap width is determined by the atomic layer deposition (ALD). Alternatively, CVD or molecular beam epitaxial are also applicable for defining the gap-width. The gap-width can be down to a few nanometer to sub nanometer. Here is a list of some of the publications where you can find the fabrication techniques. 
  • asked a question related to Nano Biomedicine
Question
4 answers
Dear all,
I'm very interested in synthesis and surface modification of iron oxide nanoparticles for biomedical applications.
Recently, I developed a amine-rich iron oxide nanoparticles and confirmed their perfect dispersion in 0.9 wt.% saline right after the purification process, however they have precipitated within a week.
As I understood, even the strongly-bound surface capping agents have their own dissociation constant. Such thing never happened in only PEG-coated nanoparticle, thus I guess the detached amine ligands were failed to re-bind with the nanoparticle surfaces due to the electrostatic charge interaction with anions.
Please give any idea or helpful references for better understandings :)
Relevant answer
Answer
Dear Chaedong,
I don't get the complete picture from just the text description. In the beginning you mention no ligands, you just state that the particle is amine rich; is there also a flexible chain involved (steric interactions) or just the charge? Maybe a drawing of your ligand structures and what you think is happening would make it easier to comment on.  
  • asked a question related to Nano Biomedicine
Question
3 answers
how can I study the encapsulation efficiency of essential oil loaded chitosan nanoparticles via GC or UV-VIS?
Relevant answer
Answer
dear Amr
GC-MS  is suitable for your study
good luck
alfekaiki
  • asked a question related to Nano Biomedicine
Question
4 answers
Hello,
I have a very peculiar bioanalyzer ladder result from a RNA Nano run. Has anyone ever seen anything like this? Currently I think this may be have to do with a lack of pressure in the chip priming station as after the 30s when I released the plunger from the clip, the plunger returned very quickly to almost the 1ml mark. Another possibility might be insufficient denaturation of the ladder?
Any input would be appreciated.
Relevant answer
Answer
Thank you Swati.
  • asked a question related to Nano Biomedicine
Question
9 answers
Hi, I am trying to obtain HOOC–PEG–COOH by oxidizing HO–PEG–OH in the presence of KMnO4 as oxidizer. I dissolved 5 g PEG-OH and 10 g KMnO4 in 50 ml dH2O and stirred overnight. Then I added 10 ml HCl, then again stirred. The next day I filtered out and obtained black precipitate. I characterized by FTIR, but I did not see HOOC–PEG–COOH. Then I changed my procedure; I dissolved 5 g PEG-OH in 25 ml NaOH, and 10 g KMnO4 in 125 ml dH2O. Then I added KMnO4 on PEG and stirred overnight. The next day I filtered out and obtained transparent solution. I added HCl on solution until pH=2, then again stirred a few minutes. Still, there is a problem.
Please, could anyone suggest me a protocol to oxidize HO–PEG–OH with KMnO4? Also, I have problems to purify HOOC–PEG–COOH.
Sincerely,
thank you for all
Relevant answer
Answer
I will suggest you to use succinic anhydride to add COOH group to terminal OH..
  • asked a question related to Nano Biomedicine
Question
6 answers
I want to coat a PLGA nano-capsule with Chitosan and TMC and Mannosilated Chitosan, but after centrifuge the coated nano particle size increased.
centrifuge details: 20000g for 5 min with glycerin bed in falcons.
3 hour steered in 10cc PVA 0.3% to evaporate organic phase and particle hardening.
size before centrifuge: Z- average 260 nm PdI 0.234
size after centrifuge: Z- average 2350 nm PdI 0.583
in another try i changed the centrifuging as below:
centrifuge details: 10000g(8500rpm) for 10 min with glycerin bed in falcons.
3 hour steered in 10cc PVA 0.3% to evaporate organic phase and particle hardening.
size before centrifuge: Z- average 250 nm PdI 0.230
size after centrifuge: Z- average 2116 nm PdI 0.583
so again i had aggregation.
Relevant answer
Answer
In my opinion it is not necessarily the problem of your system but rather of the duration of your centrifugation step. Derived from the Stokes equation you obtain the following expression for the settling velocity of your particles:
V = d^2 (p_p - p_f)*g/(18*n)
where V is the settling velocity, d is the particle diameter, p_p is the particle density (for chitosan-TPP particles ~1.3 g/cm^3), p_f is the fluid density (~1 g/cm^3 for aqueous solutions), g is the gravitational force during centrifugation and n is the viscosity of the fluid (~1 mPa*s for aqueous solutions).
You can repeat the math, but to isolate particles in a small reaction tube (1 cm) with 250 nm you need to centrifuge ~16 min at 10000g. However, if you also want smaller particles from your distribution, say all particles up to 150 nm, you need to centrifuge for ~45 min. I also attach an excel sheet with the calculations.
If you now measure your isolated particles, they will always be bigger than the original population since you loose small particles during the process. If after this, your particles are still too big, then there is probably a problem with the stability of your system.
  • asked a question related to Nano Biomedicine
Question
8 answers
Please suggest major chemical species available in the leaf extract, responsible for reduction of Ag nitrate to Ag NPs.
Relevant answer
Answer
if u want to synthesize silver NPs go for currry leaf extract since it contain carbazoles or go for neem leaf extract. it will produce NPs within some hours.
  • asked a question related to Nano Biomedicine
Question
5 answers
The drug is hydrophobic . The solubility of drug  is less than 0.5 mg/ml in water, methanol and ethanol. But drug has very good solubility in DMSO. Is it good to use DMSO as the only solvent to load the drug in nanoparticles? How to remove DMSO completely from nanoparticles? The combination of 10% DMSO and 90 % water is correct or wrong? 
Relevant answer
Answer
You shouldn't use a too good solvent for the drug; then the drug will rather remain in the solvent phase than adsorb to the silica surface. Actually wrote a paper on this almost ten years ago ;-) http://www.sciencedirect.com/science/article/pii/S0168365908001211
  • asked a question related to Nano Biomedicine
Question
7 answers
I am working on nanoparticles for the treatment of cancer. I am working with hydrophobic and hydrophilic drug. usually people (in papers) use 24 hrs for loading of drug in nanoparticle. My question is that if we increase the loading time like 48 hrs, 72 hrs, 96 hrs etc drug loading in nanoparticle will increase or not? what are the factors that are important for loading of drug in nanoparticle?
Relevant answer
Answer
With loading time increasing, the loaded amount will tend to saturation state. So yes, if you increase loading time, the loaded amount may increase but usually not much. Also, 24 hrs is not a fixed time for drug loading. The properties like hydrophilic or stability will also influence it. The factors influencing drug loading mainly focuse on the loading method (linkage, encapsulation et. al), properties of drugs (hydrophilic or hydrophobic, stability et al.), properties of nanomaterials (porous structure? 2D material? surface functionalization?), and the environment (temperature, pressure, properties of solution system et. al). Many works has paid attention on this domain. You can find some related review and read it.
  • asked a question related to Nano Biomedicine
Question
2 answers
I need to test the concentration- dependant uptake of nanoparticles. Can anyone give different options for hydroponic medium (both commercially available and composition for medium)
Relevant answer
Answer
Dear Aswathy J.:
See our article on the effect of small concentrations of the nanoparticles on plant development. They will be useful for your work.
Best regards.
  • asked a question related to Nano Biomedicine
Question
2 answers
Decrease of surface to volume ratio in spherical nanoparticles led to red-shift in SPR diagram. But in same size nanoparticles, shape alteration, from sphere to cube, with respect to increase of surface to volume ratio, caused red-shift in SPR diagram. It means there are other factors could have an affect on the SPR.
Relevant answer
Answer
SPR is the excitation of surface electrons. Increase in size will lead the red shift means decrease in the surface electrons
  • asked a question related to Nano Biomedicine
Question
11 answers
darker color is equal bigger size always?
Relevant answer
Answer
Agree with Aki. Dear Nejad change in colour is due to the change in size of your nanoparticles
  • asked a question related to Nano Biomedicine
Question
2 answers
Nanoporous alumina surfaces will be incubated with solutions of individual proteins viz. albumin, laminin and fibronectin. Then trypsin will be used to digest the proteins to produce peptides that can be analyzed and quantified by MALDI-TOF mass spectrometry. It would be helpful to get some information/insight into the incubation time with trypsin and the procedure for peptide removal from the surfaces.
Relevant answer
Answer
It will depend on how your proteins binds - interacts with the material - you have to optimise the time for digestion - you may have a look at the following publications. You may also have to look into additional proteases other than trypsin.
  • asked a question related to Nano Biomedicine
Question
2 answers
recent studies have focused on nanoparticles for anticancer treatment. are there any link between nanoparticles toxicity and heavy metal associated multiple organ failure ?
Relevant answer
Answer
For Gadolinium, see nephrogenic systemic fibrosis in patients with kidney disease.
  • asked a question related to Nano Biomedicine
Question
5 answers
I want to synthesize nanofiber with diameter lesser than 10 nm which i further want to use as drug delivery system. 
Please do tell me about the same.
Thanks in Advance 
Relevant answer
Answer
Load your drug on a suitable polymer (biodegradable ones are the best) then use electrospinning at high voltage after dissolving the polymer loaded drug in a suitable solvent (water is not preferred) to make a scaffold of the polymer bearing the drug. Many articles are available in this field. You can use the keywords you have like the name of the drug, the polymer, the solvent together with the word electrospinning to get a unique result.
  • asked a question related to Nano Biomedicine
Question
2 answers
with the intention to delivery to lung alveoli for slow liposome release into systemic circulation?
Relevant answer
Answer
Hi Chris,
i don't see why not. It well know that liposomes can be loaded into hydrogel. the question is:  will the get out? but to know that you'll have to try.
one important thing is to make sure that the PGLA solution and the liposomes suspension have the same osmomolarity otherwise you will destroy them.
check the literature for liposomes in hydrogel you'll find some already working system.
hope it helped
regards,
Etienne
  • asked a question related to Nano Biomedicine
Question
1 answer
Will EGCG be incorporated within the particle? If so, will it still be potent as an antioxidant or not? Please send me a source for further readings about green synthesis.
Relevant answer
Answer
Dear Doaa Abdelmonsif ,
 Please find the below patent for  Process for the Egcg stabilized gold nanoparticles and method for making same 
Patent no :WO 2014071190 A1 I hope my answer is helpful for you.
  • asked a question related to Nano Biomedicine
Question
12 answers
Dear all,
I'm studying on gold nanoparticle bioconjugation.
When I used EDC/NHS to gold nanoparticles, it aggregated, so I reacted these on ice to decrease the reaction temperature and used stabilizer.
At these point, I have a question.
Can EDC/NHS reaction  occur below 4℃?
Relevant answer
Answer
Hi Yong, did you separate the Au NPs from unreacted 3MPA before the EDC/NHS reaction?
Also, since DOX has one primary amine, it is probably worthwhile to do a one pot reaction of Au-NP-COOH + DOX + EDC in MES pH 5.5 and forget about making an NHS intermediary.
  • asked a question related to Nano Biomedicine
Question
2 answers
I have an odd data after I run my samples on zeta sizer. If I already labeled the vials correctly, is there any fact that can support my data? Mine is the hydrophobic drug of organotin compound encapsulated no some. The concentration of a drug is 10,25,50mM and surfactant is 1mM only. 
Please help.
Relevant answer
What type of vesicle you are working on?
  • asked a question related to Nano Biomedicine
Question
8 answers
Hi All,
I am working on conjugating mAbs to the surface of PLGA-PEG-MAL nanoparticles. Free thiols are added to the mAbs using Traut's reagent, which will then be added to the NP suspension.
I am wondering if anyone has had experience with this conjugation and would advise me on which concentrations and ratios of mAbs and NPs would be best.
Any help would be wonderful.
Thank you!
EF
Relevant answer
Answer
Hi Eduard,
I have had some experience in the past conjugating proteins bearing a thiol to maleimide functionalised nanoparticles (that case gold: https://www.researchgate.net/publication/265733952_Monovalent_maleimide_functionalization_of_gold_nanoparticles_via_copper-free_click_chemistry/stats).
You reaction is slightly different, in that your Ab will have quite a few thiols (how many you have you could estimate if you know the mAb structure).  My concern would be that if there are a lot of thiols on your antibodies is that you could possibly cross-link particles if the concentration of thiol-mAb is low, which I guess would be bad for you.  My advice would be to have the antibodies in a huge excess (conc. you will have to determine for yourself) over the nanoparticles, to minimize this problem.
Then you can purify your particles from the remaining unreacted Ab's.
Good luck!
  • asked a question related to Nano Biomedicine
Question
6 answers
I dissolve the starch in water through probe sonicator for the preparation of silver nanoparticles. it dissolves easily but colour is changed from white to yellow. Does it affects the particles? Can anyone help?
Relevant answer
Answer
I do not think that starch can be truely *dissolved* in water, it just forms a *dispersion*; the colour change will be due to the dispersed particles' particle size.
It is important to use correct terms, why using "dissolve" if it in contrast forms a *dispersion*? thermodynamically spoken, there can be no bigger difference between a solution and a dispersion, because a solution is an equilibrium system, a dispersion is a non-equilibrium system, i.e. *minimum* vs *maximum* energy content, or in other words: by dissolving, the system will walk to a lower energy level, by dispersing, you introduce energy from outside and finally reach a (much!) higher energy level than before.
  • asked a question related to Nano Biomedicine
Question
6 answers
Is the indirect method (free drug concentration in supernatant) considered as exact as the indirect one? which method one is more reliable? 
Relevant answer
Answer
Entrapment efficiency gives you an idea about the %drug that is successfully entrapped/adsorbed into nanoparticles. It is calculated as follows:
%EE = [(Drug added - Free "unentrapped drug")/Drug added] *100
Example: If the %EE is 30%, it means that 30% of your drug is entrapped into the nanoparticles.
Loading capacity helps you to deal with nanoparticles after their separation from the medium and to know their drug content. It is calculated using the following equation:
%LC = [Entrapped Drug/nanoparticles weight] * 100
Example: If the loading capacity is 30%, it means that 30% of the nanoparticles weight is composed of the drug! i.e. Each 1 mg nanoparticles contains 0.3 mg drug.
  • asked a question related to Nano Biomedicine
Question
1 answer
i plotted % released vs time as release obeyed zero order kinetic, so how can i calculate time required for release 50% of drug content ( NB. i already have slope value = 6.004)
Relevant answer
Answer
Dear Ahmed,
In Zero Order Kinetics, the rate of a reaction does not depend on the substrate concentration. In other words, saturating the amount of substrate does not speed up the rate of the reaction. Linear line is obtained when plotting a graph of time (t) vs. concentration [A] in a zero order reaction; the slope of this plot is a straight line with negative slope equal negative k, the half-life of zero order reaction decrease as the concentration decrease.
The zero order kinetic rate law is as followed, where [A] is the current concentration, [A] is the initial concentration, and k is the reaction constant and t is time:
[A]=[A]0­−kt    
In order to find the half life we need to isolate it on its own, and divide it by 2. We would end up with a formula as such depict how long it takes for the initial concentration to dwindle by half:
t1/2=[A]0­/2k
The t1/2 formula for a zero order reaction suggests the half-life depends on the amount of initial concentration and rate constant. 
Therefore, in order to find the value of time required for release of 50% of drug content, you should divide the initial concentration by twice the reaction rate that you get from the slope of the linear plot.
Hoping this will be helpful,
Rafik
  • asked a question related to Nano Biomedicine
Question
3 answers
If we are using PBS  as our release media and if the drug is not soluble in the media how can we study the release of that drug?
  • asked a question related to Nano Biomedicine
Question
5 answers
How to design nano-particulate system to which water soluble protein drugs may be encapsulated with a thermodynamically favoured process and with preserved native conformation??
Relevant answer
Answer
You have to use a good experimental design software for your work!
You can see my new publication in below link
  • asked a question related to Nano Biomedicine
Question
4 answers
Fe nanoparticles coated with polymer have been developed as drug carriers. Particle size <50 nm.
They are highly insoluble in organic solvents including DMSO or Ethanol.
Due to their solubility issue, their dilution is also a hassle.
We have tried sonicating the samples prior to dosing the cells.
Everytime the result is "nontoxic" even with dose as high as 2mg/ml.
I doubt that the nanoparticles are not interacting with the cells to manifest biological effects.
Relevant answer
Answer
Hello,
Iron nanoparticles are dense and solid spheres and they will not be soluble in any solvent. Citric acid capped very small particles of iron are only soluble in water and some solvents. The polymer coating will completely modify the properties of the underlying nanoparticles. You have not specified the polymer incase it is a biocompatible and water soluble polymer then only the particles can be soluble but it strongly depend upon the core diameter. Anyway you will get huge no. of references reporting iron oxide OR iorn nanoparticles for biomedical use and their interaction with cells. It is a well explored topic of research.
  • asked a question related to Nano Biomedicine
Question
10 answers
I want to know the silver conc in my AgNP Solution in PPM, which synthesized in laboratory.  
Relevant answer
Answer
Hello,
You should specify which type of silver you want to measure.
If you wish to measure total silver (soluble + insoluble) you can performe nitric acid digestion and atomic absorption spectrometry.
If you want to measure soluble silver, you should first ultracentrifuge the solution to sediment the insoluble silver particles. Then use supernatant to measure silver as mentioned above.
Subtract soluble silver from total silver to attain insoluble silver.
If you want to determine silver as ppm scale, you can use all atomic absorption spoctrometry methods.
  • asked a question related to Nano Biomedicine
Question
44 answers
I prepared chitosan nanoparticles some have got 0.2 and others are in the range of 0.4 - 0.5.
Relevant answer
Answer
Polydispersity Index is dimensionless and scaled such that values smaller than 0.05 are rarely seen other than with highly monodisperse standards. Values greater than 0.7 indicate that the sample has a very broad size distribution and is probably not suitable for the DLS technique. The various size distribution algorithms work with data that falls between these tow extremes. The calculations for these parameters are defined in the ISO standard document 13321:1996 E and ISO 22412:2008
  • asked a question related to Nano Biomedicine
Question
6 answers
Hello dear colleagues;
Please anyone can help me with a simple way to coat iron based magnetic nano-particles after preparation? I already prepared the particles from glass crystallization and  i want to test the bio-activity of these particles but i have a problem with agglomeration . I have tried once with PVA and I got a thin film after drying the polymer in vacuum oven. I want to dissolve these particles in NaCl to get injected in a mice blood. I want to now how to coat these particles with  dextran and mix it with NaCl
Relevant answer
Answer
The preparation should be possible with nearly any modification (anion). But use the special properties of the material (that means magnetic sedimentation) in combination with dialysis. You may find a simple procedure within the attached publications.
  • asked a question related to Nano Biomedicine
Question
1 answer
We are interested in taking multiple CBFR measurements in a single rat using microspheres. The ideal protocol would involve administering microspheres at baseline and with dobutamine stimulation under control conditions, followed by washing out the dobutamine, administering our treatment, and repeating microsphere administration at baseline and with dobutamine. Being able to perform control and treatment measures in the same animal will save resources and help eliminate the influence of biological variability in our data. Has anyone attempted such a protocol before or come across any papers that use such a method? Thanks for any input!
Relevant answer
Answer
Microspheres should remain in the myocardium for prolonged periods. In years past we did such experiments and waited weeks between measurements. Are you obtaining a reference blood sample during microsphere injection? This is essential if you want to accurately quantify regional blood flow. Also, I would use adenosine rather than dobutamine.
  • asked a question related to Nano Biomedicine
Question
4 answers
Hi, I'm planning on adapting the methodology from this paper (http://www.nature.com/nprot/journal/v3/n2/full/nprot.2008.1.html) in order to produce a visual color change for the addition of an antigen to a solution of the conjugate (AuNP+Antibody).
I was wondering if
1. i could use a NH2-PEG-SH linker
2. whether the color change would be visible at those concentrations
3. if there is anyone who has any other advice or improvements
Thanks
Relevant answer
Answer
You can please download pdfs of the files attached herewith.
  • asked a question related to Nano Biomedicine
Question
4 answers
The synthesized PEI-Dexamethasone were not dissolved after lyophilization. The reasones of this phenomena and the solutions, please.
Relevant answer
You may need to reduce the quantity of PEI.  Alternative way is to adjust the pH of PEI-Dexamethasone solution to around pH 4 using acid prior to  lyophilization.  Note PEI is insoluble in cold water.
  • asked a question related to Nano Biomedicine
Question
2 answers
I dont wish to use antigens for such targeting.
Relevant answer
Answer
Dear Shailendra Singh,
The best option would be to use the Magnetofection*** method for in vivo transfection.
Magnetofectin uses magnetic nanoparticles to complex nucleic acid to deliver and thus, when injected in vivo, the transfection can be targeted simply by an external magnetic field developped by a small magnet.
you can find more information on the in vivo method and on our reagents dedicated to this application, in the following links.
Would you have any question, please do not hesitate to contact me directly at tech@ozbiosciences.com or via ResearchGate.
Good luck with your experiment,
best regards,
Cedric
MAGNETOFECTION
*** The Magnetofection technology uses a magnetic field to attract and concentrate complexes of magnetic nanoparticles and nucleic acid onto the cell surface as demonstrated by Grześkowiak BF et al, Pharm Res. 2014 Jul 18. (http://www.ncbi.nlm.nih.gov/pubmed/25033763).
  • asked a question related to Nano Biomedicine
Question
4 answers
I am formulating a food supplement (nano-particle + papeine enzyme) that can be used as an alternative for those who are diagnosed with colorectal cancer that are MDR.  Yes it can also be a "preventive measure".  Genes of those with family history of colorectal cancers may also be prone to have liver or breast cancer, and yes, i am searching for a specific biodegradable nona-particle (to become a food supplement) that may be used to prevent cancers from worsening and/or occurring. Thank you for your help. 
Relevant answer
Answer
You will face problems, serious problems, going for oral delivery of nanoparticles. It is not impossible, but they really have to deal with lots of unfavorable conditions in the GI tract, mainly acidic gastric environment and the continuous secretion of mucus that protects the GI tract.
So, you have to find something which is acid resistant (and this likely takes all the polyesters out of the game, even though PLGA/PLA, with and without PEG have been used) and can adhere and permeate the mucus. This limits the choice to polysaccharides (better if they contain a glucosamine unit), methacrylates and polysterene particles, which of course are not biodegradable.
Ideally, you may want to try to cover PLGA particles with chitosan, but you will have major problems encapsulating the enzyme in this system.
  • asked a question related to Nano Biomedicine
Question
3 answers
i have modified my nanoparticles with NH2 groups on the surface 
Relevant answer
Answer
Ionic bond is highly sensitive to pH so if you claim that your nanoparticle-bacteria complex interacted through ionic bond you should somehow show that at an special range of pH, nanoparticle-bacteria complex is formed and at other pH values this bonds break. So a simple pH titration via simple spectroscopies which depend on nanoparticles type  should be done. For example in the case of gold, silver or Zno(zinc oxide) nanoparticles you can use Uv-Vis spectroscopy.
Best wishes 
  • asked a question related to Nano Biomedicine
Question
6 answers
I have prepared the lipid polymer hybrid nano particles using PLGA, lecithin and DSPE-PEG. Size of nano particle is around 80 nm. I want to know that how can i calculate the number of DSPE-PEG molecules forming a layer on the surface of nano particle?
Relevant answer
Answer
If you want to do it theoretically, then I think it may be even harder. Unless you simply model ideal conditions, like having 86000 lipid molecules per 100 nm diameter, single bilayer, perfect spherical particles and 100% incorporation of DSPE-PEG (you should know the molar ratio at which you add it).
I would be already quite careful with taking 86000 lipids/100 nm in case of PC, since you have a mixture of saturated and non-saturated side chains, sometimes of variable length too, that would not pack as well as phospholipids with defined saturation and length.
Even then, you have to know if the 86000 lipids are calculated based on their volume or on their surface. From that, you could simply calculate the ratio between a sphere of radius 50 nm and a sphere of radius 40 nm (surface of a sphere: 4 r^2 pi, volume 4/3 r^3 pi).
Once you found out the number you want, just multiple by % DSPE-PEG and you will get the number of DSPE-PEG molecule in the vesicle. But again, this is a very coarse approximation, which doesn't take into account packing of lipids and cholesterol.
Another method, if you are familiar with modelling (and I am not), would simply be to feed a simulation with the expected number of molecule of PC, DSPE-PEG and Chol and see if you end up having liposomes of approximately 80 nm. Maybe you can also constrain the size to 80 nm and the see how many molecules are forming the actual vesicle.
  • asked a question related to Nano Biomedicine
Question
3 answers
I am doing cell viability test (WST-1) on THP-1 cell induced by nanoparticle. The % cell viabilty decrease until 32ug/ml but increase a little bit at higher concentration. Can anyone give me reasonable explaination for that? Thank you!
Relevant answer
Answer
Agree with Tian.  I obtained similar data for some plant extracts and higher readings were actually due to extract interference. If you want to do various time points, try using a negative control (medium + nanoparticle + WST1 without cells) for each nanoparticle concentration.  Subtract these readings from experimental with cells.
  • asked a question related to Nano Biomedicine
Question
1 answer
Cdots are used as capping agents
Is there a method to know how many cdots have attached quantitatively
Relevant answer
Answer
Hi Ronak,
You may quantify the trace of carbon (cdots) coated on particles by the followings:
1) TEM and EDAX
2) Fluorescence spectroscopy (e.g. quenching effect of nano particles)
3) UV/vis spectroscopy
  • asked a question related to Nano Biomedicine
Question
6 answers
I would like to ask about a suitable protocol for synthesis of chitosan/siRNA complex and should it include poloxamer 188 as a stabilizer or not. Can I use poloxamer 407 instead?
Relevant answer
Answer
It depends a lot on the setup of your experiment. Is it an in vivo or an in vitro protocol?
For an in vitro experiment, adding a poloxamer in the formulation may not be very useful, unless you want to prepare for an in vivo assay.
  • asked a question related to Nano Biomedicine
Question
2 answers
I want to attach my drug having carboxyl grp with BSA protected Au-25 nanoclusters using EDC-NHS. What concentrations of drug, nanoclusters and EDC-NHS should I take??? Also, is it possible to bind the two using hydrophobic interactions using SDS to lower surface tension of BSA???? Kindly help me out..
Relevant answer
Answer
thank u so much nicholas :) 
my drug has only one -COOH group. The book you mentioned, I will surely refer to that.  
  • asked a question related to Nano Biomedicine
Question
3 answers
Something that can be used in aqueous media to prevent microorganism growth, and that is does not show UV absorption between 200 - 300 nm?
Relevant answer
Answer
Dear Annette,
Wavelengths below 210 and above 400 nm can be eliminated with a filter solution (1.14 mol l−1 NiSO4 / 0.21 mol l−1 CoSO4 / 0.01 mol l−1 H2SO4).
G Michael
  • asked a question related to Nano Biomedicine
Question
4 answers
Actually I am able to synthesis anticancer drug conjugated gold nano particles by using CTAB, but I could not synthesis gold alone so please suggest me good method.
Relevant answer
Answer
Refer 
Synthesis and Self-Assembly of Cetyltrimethylammonium Bromide-Capped Gold Nanoparticles, Langmuir 2003, 19, 9434-9439
  • asked a question related to Nano Biomedicine
Question
8 answers
For drugs, we can use the UV Vis spectrophotometry in permeation experiments, but how can the permeation of particles be checked? (Particles are soft, around 200-400 nm)
Relevant answer
Answer
Better way you can use the permeable membrane, which resembles the skin. Then by using physiological buffer you can measure how much amount of nano-particles crossed that membrane.
  • asked a question related to Nano Biomedicine
Question
3 answers
Can anyone please suggest any paper to do bio distribution of metal nanoparticles using NMR/Mass spectroscopy. Also, please suggest how to prepare the samples for those spectra. 
Relevant answer
Answer
Thanks both you for your answer.
  • asked a question related to Nano Biomedicine
Question
1 answer
I've done the FRAP assay by using 1 ml of sample extract which resulted in high concentration so can anyone please help me with the correct protocol?
Relevant answer
Answer
Concentrations of antioxidants and phytochemicals vary in plants depending on soils and type of fertilizers used, trace minerals in soils etc and what time of day the plant is harvested for extraction. You need to develop your own protocols for each plant. (Cannot reveal more due to proprietary interest).
  • asked a question related to Nano Biomedicine
Question
9 answers
In my lab first we tried to make gold iron nanoparticles but nanoparticles always get aggregated.Now i am looking for a company who sells nanoparticles having iron core with gold shell but could`t able to find any company.Please let me know, if anyone knows a company who do sell and about their service.
Relevant answer
Answer
That alibaba site doesn`t seems proper
  • asked a question related to Nano Biomedicine
Question
7 answers
I am working with using gold nanoparticles to find sequence specific proteins.For control,  I attached the thiolated sequence specific oligo (sequence specific to one dna binding protein) to gold nanoparticle. I transfect the nanoparticle inside the cell but I am getting lot of noise. I am getting many non specific protein attached to my nanoparticle only. I did the MS . It has 135 proteins including albumin of serum media. I heard of innovacoat of innova biosciences in which there coating material will not react to any protein inside the cell and proteins will bind to my oligo.Is there any thing like that or any protocol of coating nanoaprticle. I am confused. Help please.
Relevant answer
Answer
PEG can help reduce protein adsorption. There is commercial lipoic acid-PEG-maleimide molecule you can purchase to still be able to use thiolated DNA on top of the PEG coating. However, I would always expect a protein corona around DNA coated particles, irrespective of the specific DNA sequence. There is a lot of work on protein corona out there, just search for it.
  • asked a question related to Nano Biomedicine
Question
5 answers
I have developed a nanoformulation for hepatic carcinoma. Now i'm going for cell line studies. I would like to know if the results of liver cancer cell line studies are enough or it is important to carry out in-vivo studies on rats. 
Relevant answer
Answer
I think that's more depends on your destination. Is it for master thesis or dissertation or business purpose maybe? And the range of impact factor of the journal you would like to publish at. And also the availability of facility and finance to complete such task.
I don't know what about in your country, but in here (Indonesia) for a master thesis, formulation and in vitro is considered sufficient. While adding more variable like in vivo testing would be enough for someone to get PhD.
As for the publication process, I think formulation of nanoparticle for cancer and in vitro test with cell lines would be enough to get you through a journal with impact factor 1-4, while adding in vivo could get you higher from 2.5. I'm not an expert, hope someone can correct me if I'm wrong.
Anyway, as from what I've seen in the field, people won't continue to in vivo test if the in vitro result is not promising. Unless they have a very good reason to do it. For example, for nanoparticle drug delivery case there is EPR (Enhanced Permeability & Retention) which help the nanoparticle to localize in cancer tissue, which might give different result compared to in vitro result (http://www.sciencedirect.com/science/article/pii/S0168365907006785). Well of course this EPR only work on nanoparticle within certain range of size, I forgot the exact number but I think it is around 100-200 nm.
Hope that help,
Radif
  • asked a question related to Nano Biomedicine
Question
5 answers
I am working on Human Aortic Smooth Muscle Cells (HASMC). Upon confluence when I change the media of Human Aortic Smooth Muscle Cells (HASMC) and wash with PBS, these cells detach from the surface making sheet like structure, If anyone has experience with these cells kindly let me know how I can overcome this problem and reduce the detachment of SMC during washing and media refreshing.
Relevant answer
Answer
Hi, I hope you sorted out cells coming off the flask problem. May I ask what media (and/or supplements) are you using? In our lab we will start working with human aortic smooth muscle cells and human aortic endothelial cells. I am trying to set up a protocol for culturing these cells. However, it seems a variety of different media and supplements are in use for these cells and I am confused which product to buy. Any help will be greatly appreciated! Thanks very much. 
  • asked a question related to Nano Biomedicine
Question
3 answers
I want to use peppermint oil and lemon oil as a core for nanocapsule preparation.
Relevant answer
Answer
Nanocapsules comprising an oil, a cationic surfactant and a polymer selected from the group consisting of polyglutamic acid (PGA), polyglutamic-polyethyleneglycol acid (PGA-PEG), hyaluronic acid (HA) and polyasparagine (PAsn) or a combination of same and, optionally, an active ingredient, with the condition that when the polymer includes polyglutamic acid or polyglutamic-polyethyleneglycol acid (PGA-PEG) the active ingredient is not a didemnin or a tamandarin. Polyglutamic acid (PGA) is a hydrophilic and biodegradable polymer made of negatively charged glutamic acid units. Due to its biological properties such as non-toxicity, its non-immunogenicity and biocompatibility, this polymer has been regarded as an important biomaterial for the development of new formulations for drug delivery. 
These systems also have advantages over larger ones (microparticles, pellets, films, sponges . . . ) in their biological applications. In fact, it is known that the interaction of a drug delivery system with a biological surface is highly conditioned by its size. Thus, the nanocapsules are able to cross mucosa and be internalized by the cells acting as drug transport systems, whilst microparticles do not have that capability. Similarly, the biodistribution of these systems is highly conditioned by size. The knowledge generated in recent years in the world of nanomedicine and drug delivery nanosystems has allowed to set a clearly defined frontier between nanometric systems (which have a sub-micron size eg. Nanoparticles and nanocapsules) and micrometer systems (microparticles and microcapsules). Besides behavioral differences in their ability to be internalized by cells and overcome complex biological barriers, in the case of formulations intended for intravenous administration of antitumor drugs the nanosize of the delivery systems is essential to prevent clogging of the blood capillaries. It is also known that the chances of nanosystems reaching tumor tissue are strictly related to their size and also by the hydrophilicity of its surface.
The nanocapsules of the system of the present invention have a mean diameter less than 1 μm, therefore responding to the definition of nanosystem, colloidal system formed from polymers with a size less than 1 μm, namely, which have a size of between 1 and 999 nm, preferably between 30 and 500 nm. The size of the nanocapsules is influenced mainly by the composition and formation conditions, and can be measured using standard procedures known to those skilled in the art and described, for example, in the experimental part below. The size thereof does not significantly vary when changing the ratio of shell compound in the formulation, in all cases obtaining nano-sized systems.It is also important to note the difference between the systems of nanocapsules and “complex”. The term “complex” is understood as the nanostructure formed by the interaction of polyelectrolytes or by polyelectrolytes and surfactants of opposite charge
  • asked a question related to Nano Biomedicine
Question
3 answers
I would like to know several methods but not processes involved in chitosan to chitosan nanoparticle.
Thank you
Relevant answer
Answer
Refer the attached article - It'll help you.
Good luck 
  • asked a question related to Nano Biomedicine
Question
2 answers
How can I compute the volumes of the cavity and trapped unit(s) for the calculation of the 'packing coefficient' for MOF, nanocapsules, etc? 
Relevant answer
Answer
There is a nitrogen gas experiment you do for catalyst evaluation of the void fraction of the particle and surface area (termed epsilon). I never did myself but i was told its pretty simple if you have the instrument for it.
  • asked a question related to Nano Biomedicine
Question
4 answers
We are planning to scale up (lab-to-industry) lipid based nano injectable systems. Kindly suggest what sort of processing equipment/technology (Microfluidizer? or any other?) helps meets the criteria like reproducibility and bulk manufacturing? Thanks a ton.
Relevant answer
Answer
We have technology which can produce low-polydispersity vesicles or nanodiscs. All these nanoparticles are self-assembled. 
  • asked a question related to Nano Biomedicine
Question
5 answers
Polysaccharides nanoparticle, plant based nanoparticles, drug delivery techniques.
Thank you.
Relevant answer
Answer
Recent strategies to develop polysaccharide-based nanomaterials for biomedical applications.
YifenJung Kwon YJK WenOh
MACROMOLECULAR RAPID COMMUNICATIONS ,2014,Vol.35(21),p.1819-1832
  • asked a question related to Nano Biomedicine
Question
8 answers
What is the best way or technique to measure the concentration of 20 nm gold nanoparticles per gram of brain areas tissues ?
Relevant answer
Answer
 Dear Heba
Without prejudice I think working on low concentrations in animal tissues require adequate equipment. I am of the same opinion as Wang Xin using ICP - MS
Best regards
Djamel 
  • asked a question related to Nano Biomedicine
Question
3 answers
I want to maintain my gold nanoparticles that produced with bacteria. Please suggest me a suitable way for their maintenance that prevent their aggregations.
Then please suggest me a solvent too.
Relevant answer
Answer
PVP would work great. A 1% solution is more than enough.
  • asked a question related to Nano Biomedicine
Question
4 answers
I am planning to synthesize a nanoparticles using organic molecules and study its anticancer activity. If anyone have suitable references for synthesis, please help me in this regard. Thank you.
Relevant answer
  • asked a question related to Nano Biomedicine
Question
5 answers
I'm raising this question on the behalf of my colleague. She is working on nano composite material synthesis.She wanted to check anti-microbial activity of the composite. Whenever, she prepares the sample, it gets settled down. So, she performed sonication before loading into the wells. But still the substances are not dissolved properly. Can someone tell me how to fix this? Any other methods are available to dissolve this?
Relevant answer
Answer
So you have to separate thoughts to deal with.  First is you are not really trying to dissolve the composite other wise it wouldn't be a composite anymore. The real question you need to address is how can you get your composite into a stable suspension.  To address this you will need to figure out the surface chemistry of your composite and then look at what you are suspending the materials in. A major drivers of getting your composites into stable suspension are going to be ionic strength of your solution and the surface chemistry of your composites. 
  • asked a question related to Nano Biomedicine
Question
11 answers
What are the various routes  they take to enter cells?
Like they may enter through ion channels or by some other physical ways
Relevant answer
Answer
Uptake is primarily by endocytosis!
  • asked a question related to Nano Biomedicine
Question
7 answers
My polymer is PLGA (65:35) and dichloromethane is the organic solvent, I am using 1% PVA as stabiliser and probe-sonicator to prepare the emulsion. After I prepare the emulsion I stirred the sample for 8 hours however the solution is still milky!!!! is this normal!!!! there is no smell for the organic solvent but I am worry from the appearance of the final solution, any suggestion?  
Relevant answer
Answer
 This means that you, most probably, have your particles 
Spin them down, wash with water, resuspend in water and spin them down again, to remove PVA, keep in mind you may have to do it a couple of times and then try to characterize them
Have a look on my publication, it might be of help, I believe it will work just fine 
All the best 
Sofia
  • asked a question related to Nano Biomedicine
Question
5 answers
Is it possible to distinguish between silver ions and silver nano-particles distribution in vivo via an imaging method or a combination? Please let me know, for now I only can find x-ray methods for imaging the particle distribution.
Relevant answer
Answer
By combining an environmental scanning electron microscope (ESEM), a gaseous analytical detector (GAS) and a peltier cooling stage, this combination technique provides near-instantaneous nanoscale characterization of interactions between individual water droplets and AgNPs. The attached publication could be helpful to gain an insight.
  • asked a question related to Nano Biomedicine
Question
12 answers
Hello all, I know its a far shot but,
I have few human PD brain slices that are fixed on to glass slides, I have to do an IHC and check for Nanoparticle toxicity. Is there any IHC marker or a protein that can be used to evaluate the presence of NP's i.e. If the patient was exposed to some sort of nanoparticles so that i can support the data i have on in-vitro with in-vivo.  
Any suggestion is welcome.
Relevant answer
Answer
Maybe it's a bit off-topic but you could check the presence of magnetic nanoparticles (e.g. metallic iron, iron oxides...) by magnetization measurements. It is a non-destructive experiment, so you'd still have your slices for further experiments.